The short version: breast calcifications are small calcium deposits that show up as white spots on a mammogram. They are very common, and most are benign. A radiologist judges them by size, shape, number, and pattern. Larger, scattered deposits almost never need follow-up. Only certain fine patterns need a biopsy, and even then, most biopsies find no cancer.

If your mammogram report mentions calcifications, that word alone tells you very little. What matters is the type. Here is how radiologists sort them, with the actual numbers.

The short answer

Calcifications are one of the two main things a radiologist looks for on a screening mammogram, alongside masses. They are a normal finding in many breasts, especially after age 50.

The report will treat them one of three ways. Clearly benign calcifications get no follow-up at all. "Probably benign" calcifications get a short-interval repeat mammogram, usually in 6 months. Suspicious calcifications get a needle biopsy. Which path you land on depends almost entirely on how the calcifications look.

What are breast calcifications?

They are deposits of calcium salts inside breast tissue. Calcium blocks X-rays, so the deposits appear as bright white specks or dots on the image. You cannot feel them, and they cause no symptoms. Nearly all are found incidentally on a screening mammogram.

One thing they are not: a sign of too much calcium in your body. Calcifications are not caused by dietary calcium or calcium supplements, according to the Cleveland Clinic. They form from local changes in the tissue itself, not from what you eat.

Macrocalcifications vs. microcalcifications: what is the difference?

Size, and with it, meaning.

Macrocalcifications are the larger deposits. They can look like rods, spheres, or popcorn on the image. The American Cancer Society notes they are most likely due to aging blood vessels or skin, old injuries, or inflammation. They become more common after age 50, are considered noncancerous, and do not need a biopsy.

Microcalcifications are tiny specks of calcium, often well under a millimeter. Most of these are also benign. But because rapidly dividing cells can leave calcium behind, certain microcalcification patterns can be the earliest visible sign of a cancer, sometimes years before anything could be felt. When microcalcifications have a suspicious look or pattern, a biopsy is recommended.

This is why calcifications matter so much for early detection. Ductal carcinoma in situ (DCIS), the non-invasive, stage 0 form of breast cancer, rarely forms a lump. It usually shows up as microcalcifications. Mammographic detection of microcalcifications aids in diagnosing 85% to 95% of DCIS cases, and DCIS accounts for roughly 20% of breast cancers found by mammography.

What causes benign calcifications?

Almost anything that changes breast tissue over time can leave calcium behind:

  • Aging arteries. Calcium in the walls of breast blood vessels, called vascular calcification, is a common age-related finding.
  • Old injuries or surgery. Fat necrosis, where injured fatty tissue heals and calcifies, is a frequent cause after a bruise, biopsy, surgery, or radiation.
  • Benign growths and cysts. Fibroadenomas often calcify as they age, producing the classic coarse "popcorn" deposit. Small cysts can hold calcium-rich fluid, called milk of calcium.
  • Secretions and skin. Calcium can settle in debris inside milk ducts, and deposits can form in the skin itself.

A radiologist can usually recognize these classic benign forms on sight. When a report describes calcifications as vascular, skin, popcorn-like, rim, or milk of calcium, that pattern is the end of the story. No biopsy, no early follow-up.

When do calcifications suggest cancer?

Two features drive suspicion: the shape of the individual specks (morphology) and how they are arranged (distribution). The ACR's BI-RADS system, the same framework behind the categories on your report, defines the suspicious shapes. Their measured risk of cancer differs enormously.

A study in the American Journal of Roentgenology measured the positive predictive value of each descriptor, meaning how often biopsied calcifications of that type turned out malignant:

  • Amorphous (hazy, powder-like specks): about 20% malignant
  • Fine pleomorphic (varied shapes and sizes): about 28% malignant
  • Fine linear or branching (thin lines tracing a duct): about 70% malignant

A later analysis using the current 5th edition of BI-RADS found a similar ladder: 15.9% for amorphous, 31.7% for coarse heterogeneous, 58.2% for fine pleomorphic, and 90.6% for fine linear or branching calcifications.

Distribution matters too. Calcifications scattered through both breasts are almost always benign. A tight cluster in one spot, or specks lined up along the path of a single duct, raises concern. Our guide to BI-RADS categories explains how these findings translate into the 0-6 score on your report, including the "probably benign" BI-RADS 3 category that carries a 2% or lower chance of cancer and is watched with a 6-month follow-up instead of a biopsy.

What happens if your calcifications look suspicious?

First, expect extra pictures. Calcifications found on a screening mammogram usually trigger a callback for magnification views, which show the specks in fine detail. Many callbacks end there, with the calcifications reclassified as benign. Our callback guide walks through that visit.

If the magnified views still look suspicious, the next step is a stereotactic core needle biopsy: an outpatient procedure that uses mammographic images to guide a needle to the exact spot, under local anesthetic. No stitches, and results typically come back within days.

Here is the number to hold onto while you wait. In a 2023 series of stereotactic biopsies done for calcifications, published in the American Journal of Clinical Pathology, 27.1% found cancer. Put the other way: roughly 7 in 10 biopsies of suspicious calcifications find no cancer at all. And of the cancers found, most were DCIS (23.7% of all biopsies); only 3.4% were invasive cancers. DCIS caught at this stage is highly treatable precisely because it has not spread.

One caveat on mammogram accuracy: calcifications are actually easier to see in dense tissue than masses are, but density still complicates the overall picture. If your report also flags dense tissue, see our guide to dense breasts.

Can deodorant look like calcifications?

Yes, and it is the most avoidable false alarm in breast imaging. Many deodorants, antiperspirants, powders, and lotions contain aluminum or other metallic particles. On a mammogram these can show up as white specks that mimic microcalcifications. The American Cancer Society advises skipping these products under your arms and on your breasts on the day of the test. We cover this and other misconceptions in our mammogram myths post.

Questions worth asking your doctor

If your report mentions calcifications, these questions will get you past the jargon:

  1. What type of calcifications do I have? "Vascular" or "popcorn" is a different conversation than "fine pleomorphic."
  2. What BI-RADS category did the radiologist assign? That number, not the word "calcification," determines what happens next.
  3. Are these new, or were they on my last mammogram? Stability over years is strong evidence a finding is benign. Bring prior images if you switched facilities.
  4. If a biopsy is recommended, what is the actual chance it finds cancer? Ask for the estimate for your specific pattern; it may be far lower than you fear.

Calcifications sit at the heart of what screening is for: catching changes too small to feel. Most of the time, the finding is a benign footnote. When it is not, it is usually the earliest, most treatable form of the disease. For how mammograms fit into the rest of your preventive care, our sister site covers preventive screenings by decade.

Last updated: August 2026. This article is for informational purposes only and does not constitute medical advice. If your mammogram report mentions calcifications, review the findings and next steps with your own physician or radiologist.